OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late stage cancer patients, but also supports research and drug development in cancer and genetic diseases.
Since its early days in 2012, OncoDNA grew into a corporate group of companies with world-renown expertise. The Group offers a unique portfolio that combines NGS services, biomarker testing, data interpretation software, and clinical decision support tools.
OncoDNA is headquartered in Belgium, and its entities – Biosequence and IntegraGen – are based in Spain, France and the United States. The Group employs over 100 employees across 9 countries, works with an international network of 35 distributors and collaborates with both European-based and US-based subcontracted accredited laboratories.
Location: Belgium, Wallonia, Cosselies
Member count: 51-200
Phone: +32 71 18 35 00
Total raised: $29.170749M
Founded date: 2012
Investors 3
| Date | Name | Website |
| - | Inventures | inventures... |
| - | Le Groupe ... | sriw.be |
| - | SFPIM | sfpim.be |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 14.02.2020 | Series B | $20.577959... | - | finsmes.co... |
| 04.09.2016 | - | $8.59279M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 17.02.2020 | Internacional: OncoDNA cierra una ronda Serie B de €19M, acu... | 17/02/2020 Nota de prensa INTERNACIONAL: ONCODNA CIERRA UNA RONDA SERIE B DE €19 MILLONES, ACUDEN ... | webcapital... |
| 14.02.2020 | OncoDNA Closes €19M Series B Funding | OncoDNA, a Gosselies, Belgium-based healthcare technology company focusedd on precision medicine, ra... | finsmes.co... |
| 14.02.2020 | Belgian OncoDNA closes €19 million Series B to expand its on... | Gosselies-based OncoDNA, the healthtech making precision medicine a reality, today announced that it... | eu-startup... |
| 04.09.2016 | OncoDNA Closes €7.7M Equity Financing Round | OncoDNA SA, a Gosselies, Belgium-based precision medicine company, closed a €7.7m equity financing r... | finsmes.co... |